Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-COMBO STERINEBS | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-12-19 | 2020-09-03 | 101702 |
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 120881 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2020-04-03 | 2020-09-03 | 110764 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2020-04-10 | 2020-09-03 | 111846 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-03 | 2020-09-03 | 95390 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-07-09 | 2020-09-03 | 119895 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2019-10-24 | 2020-09-03 | 97150 |
| ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2020-03-06 | 2020-09-03 | 107998 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-21 | 2020-09-03 | 99429 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-09-03 | 110646 |
| TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2020-04-02 | 2020-09-03 | 110676 |
| CINQAIR | 10MG | SOLUTION | Resolved | 2020-05-08 | 2020-09-03 | 114421 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2020-07-14 | 2020-09-03 | 120282 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 120917 |
| TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-08-13 | 2020-09-03 | 122201 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2020-08-20 | 2020-09-03 | 122699 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-20 | 2020-09-03 | 122720 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2020-07-30 | 2020-09-03 | 121515 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2020-07-14 | 2020-09-04 | 120271 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-03-26 | 2020-09-10 | 109556 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
| TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
| CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2020-05-14 | 2020-05-14 | 115088 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |